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Triglyceride storage is altered across various chronic health conditions necessitating various techniques to visualize and quantify
lipid droplets (LDs). Here, we describe the utilization of the BODIPY (493/503) dye in skeletal muscle as a means to analyze LDs.
We found that the dye was a convenient and simple approach to visualize LDs in both sectioned skeletal muscle and cultured
adult single ﬁbers. Furthermore, the dye was eﬀective in both ﬁxed and nonﬁxed cells, and the staining seemed unaﬀected by
permeabilization. We believe that the use of the BODIPY (493/503) dye is an acceptable alternative and, under certain conditions,
a simpler method for visualizing LDs stored within skeletal muscle.
1.Introduction
Triacylglycerol (aka triglyceride, or TAG) storage is typically
at its highest appreciable amounts in white adipose tissue.
TAGs are stored within the organelles termed neutral lipid
droplets (LDs). Previous studies have shown that under vari-
ous conditions, appreciable LD accumulation can also occur
i no t h e rt i s s u e s ,s u c ha ss k e l e t a lm u s c l e .T h ea p p e a r a n c eo f
LDs in nonadipose depots is often referred to as “ectopic
fat”. Increasing amounts of ectopic fat are associated with
a number of clinical conditions, such as peripheral insulin
resistance and muscular dystrophies [1–3]. Thus, the ability
to measure or visualize the accumulation of stored TAG in
the form of LDs in skeletal muscle is important.
Measurement of lipid accumulation within skeletal mus-
cle has been performed using numerous diﬀerent method-
ologies, each with their own strengths and weaknesses. Total
TAG concentration can be quantiﬁed through biochemical
extraction, magnetic spectroscopy, or visually analyzed with
Oil Red O (ORO) or Nile Red histochemical staining of
tissue sections [4]. Each approach has unique advantages
and disadvantages. The use of ORO has become the most
commonly used approach to visualize LDs within a section
of skeletal muscle [4–7]. Since LD frequency is correlated
with the oxidative potential of the muscle ﬁber, there often
is an uneven distribution of ﬁbers that contain a signiﬁcant
amountofLDswithinawholemuscle.Speciﬁcally,VanLoon
et al. demonstrated that LD frequency is signiﬁcantly higher
in type I ﬁbers compared to type II ﬁbers, albeit there was
no distinction between the subtypes of the type II ﬁbers
in this study [8]. Thus, it is often necessary to consider
the amount of LDs in a ﬁber-by-ﬁber approach. Staining
of the ﬁbers allows the investigator to consider multiple
labeling approaches for colocalization studies. This approach
precludes experimental bias from extracellular TAG that is
often found in skeletal muscle, but not within the muscle
ﬁber itself.
The use of ORO as a means to measure LDs in a ﬁber-
speciﬁc manner is a very powerful and useful technique
for muscle biologists. However, the use of ORO is not
without experimental disadvantages. For example, the tissue
of interest requires ﬁxation, preventing its use on live cells.
In addition, completely dissolving ORO into solution can
be challenging. It is typically dissolved in isopropanol, may
requireheatingtoencouragetheprocess,andmustbeﬁltered
afterwards, which often reduces the ﬁnal concentration of2 Journal of Biomedicine and Biotechnology
the solution. Once in solution, the ORO has a limited shelf
life, thus requiring the solution to be remade frequently.
Finally, the ORO staining process requires the handling and
disposal of a signiﬁcant amount of hazardous chemicals. For
a number of years, adipocyte biologists have used an alter-
native approach to ORO to visualize LDs within adipocytes,
speciﬁcally a cell permeable lipophilic ﬂuorescence dye,
BODIPY (493/503), which emits bright green ﬂuorescence
[9]. The dye stains neutral LDs in live or ﬁxed cells and can
be successfully coupled with other staining and/or labeling
approaches. An advantage of the dye is that it requires little
eﬀort to place into solution and, unlike ORO, does not need
to be made “fresh” for each use.
The purpose of this paper is to demonstrate the use
of BODIPY (493/503) to image LDs within skeletal muscle
ﬁbers as an alternative to ORO. In order to determine its
ﬂexibility of use, we examined the use of BODIPY (493/503)
underavarietyofconditionsthatincludedfrozenmuscleand
freshly cultured single muscle ﬁbers.
2. Methods
2.1. Animals. A variety of skeletal muscles were removed
from male Sprague-Dawley rats (∼275g) and male C57BL/
10ScSn mice (∼32g) while under inhalation anesthesia (∼3–
5% isoﬂurane via a nosecone using a precision vaporizer, cat
# 91103, Vet Equip, Inc, Pleasanton, Calif, USA) just prior to
sacriﬁce.AllanimalprocedureswereapprovedbytheAnimal
Care and Use Committee at the University of Maryland.
2.2. Muscle Fiber Sections. Rat tibialis anterior (TA) muscles
were isolated and frozen in liquid nitrogen-cooled isopen-
tane. They were stored at −80◦C, and transverse sections
were cut on a cryostat (10µm thick) and collected onto glass
slides (Superfrost Plus; VWR, Westchester, Pa, USA).
2.3. Single Fiber Isolation. Intact single muscle ﬁbers were
isolated from the ﬂexor digitorium brevis (FDB) muscle
of adult mice according to previously described techniques
[10]. Brieﬂy, surgically excised FDB muscles were incubated
in dissociation media (DM) containing DMEM, 1µL/mL
gentamycin, 0.2% BSA, and 4mg/mL of collagenase A
(Sigma, C0130). FDB muscles were placed in a 35mm dish
with 4mLs DM and then in an incubator (37◦,5 %C O 2)
for 2 hours. Following the dissociation, muscles were placed
in a new 35mm plate with fresh media and triturated with
as m a l lb o r e( ∼1mm) ﬁre polished glass transfer pipette
to yield single FDB myoﬁbers. Following the trituration
process, ﬁbers were plated onto extracellular matrix- (ECM,
Sigma E1270) coated dishes (Matek, P35G-1.0-14-C). Fibers
were allowed to incubate overnight before staining and/or
immunolabeling. Some dishes were incubated overnight in
a high-fat media containing equal molar concentrations of
palmitate (PA) and oleate (OA) (0.5mM of each thus a ﬁnal
concentration 1.0mM) to induce LD formation in the ﬁbers.
The palmitate and oleate were conjugated to 2% fatty acid-
freebovineserumalbuminwhichwouldbeexpectedtoresult
in a ﬁnal ratio of NEFA to BSA of 2.5:1.0, as previously
described [11]. We have found no evidence of toxicity when
cells are treated with both palmitate and oleate, although
we have found evidence of toxicity if cells are treated with
palmitate alone.
2.4. BODIPY (493/503) Staining and Visualization. BODIPY
(D3922, Molecular Probes, Carlsbad, Calif, USA) (excita-
tion wavelength 480nm, emission maximum 515nm), was
diluted in PBS or DMSO at a concentration of 1mg/mL
and applied to cross sections or FDB ﬁbers, respectively,
for 30mins. We assessed both ﬁxed (4% paraformalde-
hyde for 5mins) and unﬁxed sections, as well as ﬁxed
(4% paraformaldehyde for 5mins) and live FDB ﬁbers;
4,6-diamidino-2-phenylindole (DAPI) was used to identify
nuclei. Following ﬁxation, samples were washed 3 times in
phosphate-buﬀered saline (PBS) for 10mins. Some cross
sections were stained with 5ug/mL rhodamine-labeled suc-
cinylated wheat germ agglutinin (WGA, RL1022S; Vector
Laboratories, Burlingame, Calif, USA), and some were
labeled with antibodies (monoclonal slow myosin, M4276,
Sigma, St Louis, Mo, USA) to identify slow (Type I) muscle
ﬁbers. For immunolabeling, sections were washed for 10
minutes in 100mmol glycine phosphate-buﬀered saline
(glycine PBS), blocked for 1 hour in 1% bovine serum albu-
min PBS (BSA-PBS), and then incubated for 2 hours with
primary antibodies diluted to 2mg/mL in PBS. The tissue
sections were then washed 3 times with 1% BSA/PBS for 10
minutes before incubation with species-speciﬁc secondary
antibodies coupled to Alexa dye 568 (Invitrogen, Carlsbad,
Calif, USA) (dilution of 1:100). All samples were mounted
in VECTASHIELD (Vector Laboratories) and covered with
glass cover slips (No. 1, VWR). We examined samples under
epiﬂuorescent optics, and digital images were obtained with
a Zeiss 510 confocal laser scanning microscope.
2.5. Oil Red O Staining. Serial sections (10µM) from frozen
rat TA muscle were used. The ﬁrst half of the serial
sections were stained with BODIPY as described above.
The remaining samples were air dried onto a glass slide
and then ﬁxed in formalin for 5 minutes, followed by a 1
minute wash with tap water. Next, slides were rinsed with
60% isopropanol then stained with a ﬁltered 5% Oil Red O
solution for 30 minutes. After Oil Red O staining, slides were
rinsed with 60% isopropanol. All samples were mounted
in VECTASHIELD (Vector Laboratories), covered with glass
cover slips (No. 1, VWR), and mounted with Permount
(Biomeda, Burlingame, Calif, USA).
3. Results
BODIPY (493/503) has become the standard dye utilized
by scientists to study LDs within adipocytes. In this study,
we sought to demonstrate that this compound can be
used to visualize LDs in skeletal muscle tissue. Using the
BODIPY (493/503), we were able to detect visible LDs
through standard epiﬂuorescence and confocal microscopy
in sections of whole rat muscle and live cultured mouse
single ﬁbers. Using cross sections of a soleus muscle takenJournal of Biomedicine and Biotechnology 3
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Figure 1: Staining of neutral lipid droplets (LDs) with BODIPY (493/503) in cross section of rat soleus muscle demonstrates staining
within the ﬁber, but especially under the surrounding sarcolemma. (a) Fibers stained with BODIPY (green) demonstrate the appearance of
spherical LDs within the muscle ﬁbers as previously described with Oil Red O staining procedures. (b) To provide anatomical localization,
the membrane is labeled with wheat germ agglutinin (WGA)-Alexa Fluor 594 (red). (c) Nuclei were stained with DAPI (Blue). (d) Merged
triple label image of the muscle section. All images were taken at 63x, and a scale bar is provided for reference.
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Figure 2: Comparison of serial cross sections from rat tibialis anterior (TA) muscle demonstrates that ORO and BODIPY staining are the
strongest in the same ﬁbers. (a) Fibers stained with ORO (red) demonstrate the appearance of spherical LDs within the muscle ﬁbers. (b)
Fibers stained with BODIPY (green) demonstrate the appearance of spherical LDs within the muscle ﬁbers.4 Journal of Biomedicine and Biotechnology
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Figure 3: Staining of LDs with BODIPY (493/503) in cross section of rat tibialis anterior (TA) muscle demonstrates that LDs are not limited
to muscle ﬁbers expressing slow MHC. (a) Fibers stained with BODIPY (green) demonstrate the appearance of spherical LDs within the
muscle ﬁbers as previously described with Oil Red O staining procedures. (b) Slow ﬁbers were labeled using an antibody speciﬁc for the
slow form of MHC (red). (c) Nuclei were stained with DAPI (Blue). (d) Merged triple label image of the muscle section demonstrates ﬁbers
presenting with substantial BODIPY signal that do not label for slow MHC. All images were taken at 10x, and a scale bar is provided for
reference.
from a rat, we found visible LDs (green, Figure 1(a))s i t u a t e d
within the muscle and along the sarcolemma, identiﬁed by
wheatgermagglutininstaining(red).Thesestainingpatterns
are very similar to our ORO images (Figures 2(a) and 2(b))
and also to previously published ORO images taken from
muscle cross sections [6, 7].
Previous publications have suggested that LDs are typ-
ically more abundant in the type I MHC-positive ﬁbers
[2, 12]. Thus, we attempted to determine if LDs stained
by BODIPY (493/503, green) were selectively found in only
type I muscle ﬁbers (red, Figures 3 and 4). Surprisingly, we
found with regular frequency that a number of ﬁbers that
contained substantial LD stain (bright ﬁbers in Figures 3 and
4)w e r en o tn e c e s s a r i l yt y p eI( Figure 3). To explore this in
greater detail, we examined additional sections at increased
magniﬁcation.WefoundthatLDsareclearlynotrestrictedto
type I ﬁbers, but are also abundant in fast ﬁbers (presumably
type IIa) (Figure 4).
To assess the use of BODIPY in live cells, we isolated and
cultured single muscle ﬁbers from the FDB of adult mice.
Fiberswereeitherplacedinstandardcultureconditionmedia
(Figures 5(a) and 5(c)) or placed in media supplemented
with equimolar concentrations of fatty acids (Figures 5(b)
and 5(d)). The ﬁbers were stained with BODIPY (493/503)
and DAPI (blue). In the ﬁbers maintained under standard
culture conditions, we found a heterogeneous mix of ﬁbers
with easily detectable LDs (Figure 5(a)) and ﬁbers with
virtually no detectable LDs (Figure 5(c)). However, when the
ﬁbers were treated overnight with the 1.0mM FA mixture,
the majority of the ﬁbers exhibited an obvious increase in
the amount of visible LDs that were found throughout the
entire length of all ﬁbers (Figures 5(b) and 5(d)). We have
detected increases in LD frequency across a range of 0.5–
1.0mM FA in cultured cells (data not shown). Furthermore,
using 3D confocal reconstruction of the treated ﬁbers, it was
clearthatLDswerelocatedthroughoutthevolumeoftheFA-
treated ﬁbers. In agreement with previous publications, the
presented Z-stack images (1µM thick, Figure 6) allow for the
appreciationofthesizeoftheLDwithinthemuscleﬁber.The
LDs in muscle are quite small (<2µM), particularly when
compared to what is found in cultured adipocytes (>10µM)
or even LDs within hepatic tissue (∼10µM).
4. Discussion
The purpose of this paper is to demonstrate the use of
BODIPY (493/503) as an alternative approach to image LDs
within skeletal muscle ﬁbers. Currently, the most common
approach to visualize LDs in skeletal muscle is through ORO
staining, which requires tissue ﬁxation and is a more time-
consuming process. From an experimental point of view,
BODIPY is a more ﬂexible approach when compared toJournal of Biomedicine and Biotechnology 5
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Figure 4: High-magniﬁcation image demonstrates the presence of LDs within nonslow muscle ﬁbers in the cross section of the rat TA. (a)
Fibers stained with BODIPY (green) demonstrate the appearance of spherical lipid droplets within the muscle ﬁbers. (b) Slow ﬁbers were
identiﬁed using an antibody speciﬁc for the slow form of MHC (red). (c) Nuclei were stained with DAPI (Blue). (d) Merged triple label
image of the muscle section demonstrates ﬁbers presenting with substantial BODIPY signal that do not label for slow MHC. All images were
taken at 63x, and a scale bar is provided for reference.
ORO. Speciﬁcally, we were able to use BODIPY on live cells
andﬁxedcellswithnoappreciablediﬀerences.Wealsofound
thatpermeabilizationdidnotaﬀectstaining,althoughothers
have noted that saponin treatment can reduce the number
of LDs [13]. We also used BODIPY on ﬁxed and unﬁxed
frozen muscle sections with equal success. We found that
ORO and BODIPY (493/503) resulted in comparable results
between serial cross sections of the same muscle, indicating
that BODIPY (493/503) is an eﬀective alternative for LD
staining in muscle. To date, only a few studies have used
BODIPY as a means for visualizing LDs in muscle. Prats
et al. used BODIPY (493/503) to show very clear staining of
LDs in the soleus muscle [13], and, in a more recent paper,
Kostominova used BODIPY to identify LDs in extraocular
and peripheral muscle [14, 15]. Unfortunately, these papers
have not resulted in increased utilization of this approach in
skeletal muscle. Thus, for whateverreason, we believe muscle
biologistsmaynotbeawareofBODIPY(493/503)asameans
for examining LD presence in skeletal muscle. To the best
of our knowledge, our current work represents the ﬁrst use
of BODIPY to identify LDs in fast-twitch skeletal muscle
isolated myoﬁbers and whole-muscle cross sections. Our
images clearly demonstrate the ease with which LDs can be
visualized using the BODIPY stain in various experimental
approaches in skeletal muscle.
A number of ﬂuorescent dyes can be employed to
visualize LD within skeletal muscle. ORO and Nile Red
have both been successfully used in skeletal muscle [5–7];
however, each has limitations that reduce their functionality
in a laboratory setting. For example, Nile Red is diﬃcult to
use in experiments that require multiple labeling, because
it emits a powerful signal spanning a large wavelength
[9]. ORO has been used with more regularity; however,
since ORO is dependent on the use of isopropanol, it can
cause the artiﬁcial fusion of LDs, making it inappropriate
f o ra n a l y s i so fL Ds i z eo rn u m b e r[ 9]. Furthermore, ORO
must be ﬁltered; tissue requires ﬁxation and can be diﬃcult
dissolve. Scientists that study LD function in nonmuscle
cells have adopted the use of BODIPY (493/503) as a means
to visualize LDs within cells. BODIPY (493/503) contains
a nonpolar structure that, upon binding to neutral lipid,
emits a green ﬂuorescence signal with a narrow wavelength
range, making it an ideal approach for using in multi-
labeling(ordye)experiments[9].Thehydrophobicnatureof
these dye molecules promotes rapid entry into the nonpolar
environmentofLDs[9].GoczeandFreemanshowedthatthe6 Journal of Biomedicine and Biotechnology
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Figure 5: Exposure of single ﬁbers to a palmitate-oleate mixture substantially increases the size and frequency of LDs within cultured mouse
single muscle ﬁbers. (a, c) Single muscle ﬁbers isolated from the FDB were doubly stained with BODIPY (493/503-green) and DAPI (blue).
The ﬁbers were cultured overnight in standard media conditions. A heterogeneous mix of ﬁbers presenting with LDs was found, in which
some ﬁbers presented with a visible number of LDs (a), while others presented with virtually no LDs (c). (b, d) Single muscle ﬁbers isolated
from the FDB were cultured overnight in standard media conditions supplemented with albumin-conjugated palmitate-oleate mixture
(0.5mM:0.5mM ratio). A substantially higher number and larger LDs were found consistently across all ﬁbers that were imaged. All images
were taken at 63x, and a scale bar is provided for reference.
lipid ﬂuorescent variability is signiﬁcantly lower when using
BODIPY (493/503) compared to Nile Red, suggesting that it
m a yb em o r es p e c i ﬁ cf o rt h eL D[ 16].
Here, we visually detected the appearance of spherical
LDs within individual skeletal muscle ﬁbers consistent with
previous descriptions [6]. In muscle cross sections, the LDs
were often in close proximity to the sarcolemma, which
suggests that sarcolemmal identiﬁcation may be critical to
determine if the LDs are located in intramuscular or inter-
muscular regions. This would be particularly critical if the
goal is quantiﬁcation of LDs within muscle ﬁbers. LDs were
found scattered throughout the individual ﬁbers (in some,
but not all) in a punctuate fashion. The punctuate pattern
and the inability to ﬁnd LDs in all ﬁbers agree with previous
descriptions and our ﬁndings of LD distribution based on
ORO staining of muscle cross sections [6]. We also found
that when staining isolated ﬁbers in standard cell culture
media, LDs were not consistently visible in all of the ﬁbers
within the culture dish. These data suggest that LDs are not
found in great frequency across all ﬁbers. However, when we
treated the isolated single ﬁbers with media containing high
concentrations of fatty acids, we found a substantial increase
in the frequency of LDs and found LD present within all
ﬁbers. As expected, we found that BODIPY (493/503) works
remarkably well in multiple-labeling approaches using both
sectioned muscle and cultured single ﬁbers. For example, we
foundthatmuscleﬁbersthatcontainedahigherfrequencyof
LDsw e r enotal wa y spositi v ef o rtypeIMHC.P r eviousl y ,van
Loon et al. demonstrated a high correlation of ORO staining
with human type I muscle ﬁbers compared to lower staining
intypeIIﬁbers[8].Ourdatasuggestatleastasubpopulation
of likely type II (e.g., perhaps IIa) ﬁbers can contain a visible
amountofLDinskeletalmuscletakenfromrodents.Overall,
our data indicate that BODIPY (493/503) can be successfully
used to image LDs within skeletal muscle using multiple
diﬀerent approaches. In addition, in much the same fashion
as it is currently done for ORO staining, it would be possible
toquantifyLDinsections[4,12] or asit waspreviouslydone
in single ﬁbers [13].
In summary, we found that BODIPY (493/503) works
well as a means to visualize LD in skeletal muscle. This versa-
tiledyeworkswellinsectionedmuscleandlivecultureunderJournal of Biomedicine and Biotechnology 7
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Figure 6: Z-stack analysis of a mouse single muscle ﬁber treated overnight with palmitate-oleate-supplemented media demonstrates
distribution of LDs throughout the entire muscle ﬁber. Single muscle ﬁbers isolated from the FDB were doublly stained with BODIPY
(493/503-green) and DAPI (blue). Consecutive 1-µm-thick confocal images are shown from Z-stacks taken near the middle of the ﬁber
(63x), and scale bar is provided for reference.
diﬀerent types of conditions. BODIPY (493/503) oﬀers a
valuable and simple alternative for investigators interested in
LD function in skeletal muscle.
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